[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Medicated Skin Care in Iran

July 2012 | 23 pages | ID: M3AF4D85062EN
Euromonitor International Ltd

US$ 990.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Like many other consumer health categories, the official OTC list for skin care contains very few products while a large number of non-OTC alternatives exist in the market. These alternatives include many forms of hair loss treatments, which are classified as toiletries, to different forms of antifungals which are not OTC in Iran. This has resulted in relatively low value growth of consumer health medicated skin care in recent years. The category saw current value growth of 13% in 2011 which...

Euromonitor International's Medicated Skin Care in Iran report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2007-2011, allowing you to identify the sectors driving growth. Forecasts to 2016 illustrate how the market is set to change.

Product coverage: Antiparasitics/Lice (Head and Body) Treatments, Antipruritics, Cold Sore Treatments, Haemorrhoid Treatments, Hair Loss Treatments, Medicated Shampoos, Nappy (Diaper) Rash Treatments, Paediatric Medicated Skin Care, Topical Allergy Remedies/Antihistamines, Topical Antifungals, Topical Germicidals/Antiseptics, Vaginal Antifungals.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?

  • Get a detailed picture of the Medicated Skin Care market;
  • Pinpoint growth sectors and identify factors driving change;
  • Understand the competitive environment, the market’s major players and leading brands;
  • Use five-year forecasts to assess how the market is predicted to develop.
Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.
MEDICATED SKIN CARE IN IRAN

Euromonitor International
August 2012

LIST OF CONTENTS AND TABLES

Headlines
Trends
Switches
Competitive Landscape
Prospects
Category Data
  Table 1 Sales of Medicated Skin Care by Category: Value 2006-2011
  Table 2 Sales of Medicated Skin Care by Category: % Value Growth 2006-2011
  Table 3 Medicated Skin Care Company Shares by Value 2007-2011
  Table 4 Medicated Skin Care Brand Shares 2008-2011
  Table 5 Hair Loss Treatments Brand Shares 2008-2011
  Table 6 Forecast Sales of Medicated Skin Care by Category: Value 2011-2016
  Table 7 Forecast Sales of Medicated Skin Care by Category: % Value Growth 2011-2016
Darou Pakhsh Pharmaceutical Mfg Co in Consumer Health (iran)
Strategic Direction
Key Facts
  Summary 1 Darou Pakhsh Pharmaceutical MFG Co: Key Facts
  Summary 2 Darou Pakhsh Pharmaceutical MFG Co: Operational Indicators
Company Background
Production
Competitive Positioning
  Summary 3 Darou Pakhsh Pharmaceutical MFG: Competitive Position 2011
Executive Summary
Consumer Health Sustains Healthy Growth in 2011 But at A Slower Pace
Economic and Political Factors Threaten Both Importers and Manufacturers
Increasing Availability of Imported Vitamins and Dietary Supplements
Distribution Mainly Only Allowed Through Chemists/pharmacies
Reduced Subsidies To Have A Significant Impact on Unit Price and Consumption
Key Trends and Developments
Major Turmoil for the Iranian Economy
Huge Young Iranian Population Remains the Main Growth Driver
Pharmacies Remain the Main Distribution Channel
Strong Influence of Self-medication and Utc Consumption
Brand Awareness of OTC Remains Limited, Unlike Vds
Market Indicators
  Table 8 Consumer Expenditure on Health Goods and Medical Services 2006-2011
  Table 9 Life Expectancy at Birth 2006-2011
Market Data
  Table 10 Sales of Consumer Health by Category: Value 2006-2011
  Table 11 Sales of Consumer Health by Category: % Value Growth 2006-2011
  Table 12 Consumer Health Company Shares 2007-2011
  Table 13 Consumer Health Brand Shares 2008-2011
  Table 14 Sales of Consumer Health by Distribution Format: % Analysis 2006-2011
  Table 15 Sales of Consumer Health by Category and Distribution Format: % Analysis 2010
  Table 16 Forecast Sales of Consumer Health by Category: Value 2011-2016
  Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2011-2016
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventative Medicine
Switches
Definitions
Sources
  Summary 4 Research Sources


More Publications